Skip to main content
ILSUNG IS CO., LTD. logo

ILSUNG IS CO., LTD. — Investor Relations & Filings

Ticker · 003120 ISIN · KR7003120003 KO Manufacturing
Filings indexed 212 across all filing types
Latest filing 2021-12-09 Director's Dealing
Country KR South Korea
Listing KO 003120

About ILSUNG IS CO., LTD.

https://www.ilsung.com/

ILSUNG IS CO., LTD. is a pharmaceutical company specializing in the development and manufacturing of therapeutic products. The company's core portfolio is focused on antibiotics, cardiovascular agents, anesthetics, and contrast media. It is actively expanding its research and development into new therapeutic areas, including treatments for gastrointestinal (GI), central nervous system (CNS), and other cardiovascular (CV) conditions.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Il-Sung Pharmaceuticals. It details specific share transactions (장내매도 - open market sale) by a company executive (윤덕근) and provides a summary of the total shareholding changes for major shareholders. This type of filing, which reports personal share transactions by company directors or major shareholders, is classified as 'Director's Dealing' (DIRS).
2021-12-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매도' or open-market sales) of an executive (윤덕근) of Il-Sung Pharmaceutical. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2021-12-09 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders and Related Parties' (최대주주등소유주식변동신고서) for Il-Sung Pharmaceuticals. It details specific transactions (장내매도, or open market sales) by an executive/director (윤덕근) and provides a comprehensive table of share ownership changes for the company's major shareholders. This falls under the category of Director's Dealing (DIRS) as it reports personal share transactions by company directors and executives.
2021-12-08 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders and Related Parties' (최대주주등소유주식변동신고서). It details specific share transactions (sales) by company executives and major shareholders, including names, dates, and the number of shares changed. This falls under the category of Director's Dealing (DIRS) as it reports personal share transactions by company insiders.
2021-12-07 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Il-Sung Pharmaceuticals. It details specific share transactions (sales) by an executive/major shareholder (윤덕근) and provides a summary of total shareholdings for major shareholders. This type of filing is a standard regulatory disclosure for insider/major shareholder transactions, which falls under the 'Director's Dealing' (DIRS) category as it reports personal share transactions by company insiders/executives.
2021-12-06 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Il-Sung Pharmaceuticals. It details specific share transactions (sales) by an executive/major shareholder (Yoon Deok-geun). This type of filing, which reports personal share transactions by company directors or major shareholders, is classified as 'Director's Dealing' (DIRS) in the provided schema.
2021-12-03 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.